Duavee
| Chemical Name | conjugated estrogens/bazedoxifene |
| Dosage Form | Tablet (oral; 0.45 mg conjugated estrogens and 20 mg bazedoxifene) |
| Drug Class | Hormones |
| System | Female reproductive |
| Company | Pfizer |
| Approval Year | 2013 |
Indication
- For the treatment of moderate to severe vasomotor symptoms associated with menopause.
- Indicated for the prevention of postmenopausal osteoporosis.
Last updated on 6/23/2022